Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ligand Pharmaceuticals (LGND) Interest Coverage Ratio (2016 - 2025)

Ligand Pharmaceuticals' Interest Coverage Ratio history spans 16 years, with the latest figure at 7.76 for Q4 2025.

  • For Q4 2025, Interest Coverage Ratio rose 171.38% year-over-year to 7.76; the TTM value through Dec 2025 reached 8.7, up 216.83%, while the annual FY2025 figure was 8.7, 216.83% up from the prior year.
  • Interest Coverage Ratio for Q4 2025 was 7.76 at Ligand Pharmaceuticals, down from 60.36 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 3078.0 in Q3 2023 and bottomed at 41.77 in Q1 2025.
  • The 5-year median for Interest Coverage Ratio is 7.54 (2025), against an average of 163.51.
  • The largest annual shift saw Interest Coverage Ratio skyrocketed 8180.5% in 2023 before it crashed 297.12% in 2025.
  • A 5-year view of Interest Coverage Ratio shows it stood at 8.44 in 2021, then skyrocketed by 501.0% to 50.73 in 2022, then tumbled by 150.53% to 25.63 in 2023, then soared by 57.62% to 10.86 in 2024, then skyrocketed by 171.38% to 7.76 in 2025.
  • Per Business Quant, the three most recent readings for LGND's Interest Coverage Ratio are 7.76 (Q4 2025), 60.36 (Q3 2025), and 7.32 (Q2 2025).